A non-interventional, prospective, multicenter study for evaluation of the use of the herbal medicinal product Canephron® N in the pediatric outpatient population in Russia

Clinical Phytoscience

International Journal of Phytomedicine and Phytotherapy

Table 5 Adverse Drug Reactions during Observational Period (Safety Set without 37 patients who started HMP intake before enrollment)

		HMP form
	Total	Oral solution	Tablets
Preferred Term	(N = 597)	(N = 393)	(N = 204)
Any treatment-emergent adverse drug reaction	5 (0.8%)	3 (0.8%)	2 (1.0%)
Dermatitis	3 (0.5%)	3 (0.8%)	0
Dyspepsia	1 (0.2%)	0	1 (0.5%)
Renal colic^a	1 (0.2%)	0	1 (0.5%)

^aRenal colic was the only serious adverse drug reaction (1 patient; unexpected)